Mind Medicine Inc logo

Mind Medicine Inc

NEW
NAS:MNMD (USA)   Ordinary Shares
$ 6.74 +0.070 (+1.05%) 12:09 AM EST
At Loss
P/B:
2.09
Market Cap:
$ 507.61M
Enterprise V:
$ 255.72M
Volume:
2.18M
Avg Vol (2M):
2.23M
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
2.18M
At Loss
Avg Vol (2M):
2.23M

Business Description

Mind Medicine Inc logo
Mind Medicine Inc
NAICS : 325199 SIC : 3741
ISIN : CA60255C8850

Share Class Description:

MNMD: Ordinary Shares
Description
Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).
Name Current Vs Industry Vs History
Cash-To-Debt 12.53
Equity-to-Asset 0.8
Debt-to-Equity 0.09
Debt-to-EBITDA -0.21
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.25
Quick Ratio 7.25
Cash Ratio 7.05

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -38.8
Shareholder Yield % -51.76

Financials (Next Earnings Date:2025-05-08 Est.)

MNMD's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:MNMD

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Mind Medicine Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -2.08
Beta 2.82
3-Year Sharpe Ratio 0.11
3-Year Sortino Ratio 0.16
Volatility % 91.03
14-Day RSI 47.91
14-Day ATR ($) 0.532734
20-Day SMA ($) 6.552
12-1 Month Momentum % -21.82
52-Week Range ($) 5.0329 - 12.22
Shares Outstanding (Mil) 75.37

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Mind Medicine Inc Filings

Filing Date Document Date Form
No Filing Data

Mind Medicine Inc Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Mind Medicine Inc Frequently Asked Questions

What is Mind Medicine Inc(MNMD)'s stock price today?
The current price of MNMD is $6.74. The 52 week high of MNMD is $12.22 and 52 week low is $5.03.
When is next earnings date of Mind Medicine Inc(MNMD)?
The next earnings date of Mind Medicine Inc(MNMD) is 2025-05-08 Est..
Does Mind Medicine Inc(MNMD) pay dividends? If so, how much?
Mind Medicine Inc(MNMD) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1